FDA is still taking a firmer line than the lobbyists would like. Will be interesting as this creeps closer to the Nov 26 deadline.
FDA not happy with current proposed work plan to undertake safety studies on the chemical ingredients - still lacking full detail they are after, and proposed time-frames for testing are far too long. FDA may shut the door on them if this is not able to be rectified by Nov 26 deadline. Note, PCPC have less than 2 weeks from the Nov 13 meeting to fix the work plan - and FDA is not going to allow them to propose ridiculously long timeframes again just to delay any decision making.
I would say the reason they did not propose conducting certain tests the FDA proposed, is because they know the outcome of such tests will not be favourable for chemicals.
Remember, FDA has done its own tests (
https://edition.cnn.com/2019/05/06/health/sunscreen-bloodstream-fda-study/index.html) which showed very poor results for chemical ingredients. This is not baseless scrutiny of chemical ingredients.
